Biobytes
CEO. Lee Jungwoo
Biobytes: AI-Powered Solutions for Sarcopenia Prediction, Built on a Proprietary Biobank
#Sarcopenia #Digital_Healthcare #Biobank
Company Info.
Main Product/Service. MyoTest, Biact Tab, Nirex Tab
Date of Establishment. December 26, 2023
Contact Info.
Company Profile
Biobytes leverages a proprietary biobank of sarcopenia patient data
to develop an AI-powered risk prediction solution and drive the discovery of novel biomarkers.
Product / Service
What makes us different
BioBytes is a company that develops AI-powered solutions for sarcopenia prediction and discovers diagnostic and therapeutic biomarkers based on biobank cohort data. We have launched and are distributing 'BiAct Tablet', a health supplement optimized for muscle synthesis and strength enhancement. Additionally, we have released 'Nyrex Tablet', a health supplement developed using KFDA-approved ingredients that help with fatigue recovery and stress relief.
Work Experience
2025
2024
2023
July / Acquired GMP and ISO certifications
May / Certified as a research-based company
Feb / Registered as a company-affiliated research institute
Dec / Certified as a venture company
Dec / Incorporated as a legal entity